NPIC is to receive funding as part of the government’s “boost for research”, aimed at the early detection and diagnosis of cancer to provide a better service for patients. As part of this investment in life sciences, NPIC are involved in three of the projects.
These collaborations bring together leading institutions across the UK and the investment will build on NPIC’s expertise by scaling up our National clinical and Research in AI capabilities.
NPIC SDE Platform Summary
- NPIC will receive investment from the government to create a national Digital Pathology research platform.
- The funding will allow NPIC to develop a proof-of-concept national platform for research
- The platform will create and share digital pathology image datasets with NHSE sub-national SDEs
“NPIC welcomes the new Government’s announcement. The investment in Digital Pathology and working with the National Secure Data Environment (SDE) will accelerate research in artificial intelligence for improving cancer diagnosis for patients.”
Prof Darren Treanor, Director of National Pathology Imaging Co-operative, NPIC
MANIFEST Programme Summary
- MANIFEST is funded by the Medical Research Council and the Office for Life Sciences, with additional matched funds from industry.
- As part of the MANIFEST programme, NPIC will help develop a national platform that integrates digital pathology and multiomic data. This platform will support researchers in identifying critical biomarkers, enhancing the ability to tailor immunotherapy treatments to individual cancer patients.
- The MANIFEST programme aims to better understand cancer patients’ responses to immunotherapy. NPIC’s advanced digital pathology imaging technology will play a key role in storing and analysing multiomic data.
“Being part of the MANIFEST programme will provide an opportunity for NPIC to advance our work in digital pathology and cancer research. This collaboration brings together leading institutions across the UK, and we are proud to contribute to an effort that has the potential to significantly impact patient outcomes.”
Dr Daljeet Bansal, Operations Director, National Pathology Imaging Co-operative, NPIC
Spotlight HMDS Summary
- NPIC will work with Spotlight Pathology Ltd, funded by Innovate UK’s Advancing Precision Medicine award
- The project will create an AI digital diagnostics platform to streamline the diagnosis of blood cancers
Further information about the government’s funding can be found here: New government tech deals boost the business of cancer detection – GOV.UK (www.gov.uk)